Nova Leap Health (TSXV:NLH) Debt-to-EBITDA : 0.72 (As of Sep. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Nova Leap Health Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Nova Leap Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was C$1.46 Mil. Nova Leap Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was C$1.44 Mil. Nova Leap Health's annualized EBITDA for the quarter that ended in Sep. 2023 was C$4.00 Mil. Nova Leap Health's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 was 0.72.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Nova Leap Health's Debt-to-EBITDA or its related term are showing as below:

TSXV:NLH' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -16.21 Med: 1.66 Max: 44.51
Current: -12.26

During the past 7 years, the highest Debt-to-EBITDA Ratio of Nova Leap Health was 44.51. The lowest was -16.21. And the median was 1.66.

TSXV:NLH's Debt-to-EBITDA is ranked worse than
100% of 423 companies
in the Healthcare Providers & Services industry
Industry Median: 2.61 vs TSXV:NLH: -12.26

Nova Leap Health Debt-to-EBITDA Historical Data

The historical data trend for Nova Leap Health's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nova Leap Health Debt-to-EBITDA Chart

Nova Leap Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-EBITDA

Get a 7-Day Free Trial

-16.21

44.51

5.50

1.66

9.44

Nova Leap Health Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Debt-to-EBITDA	Get a 7-Day Free Trial															1.09	-1.18	-12.37	210.81	0.72

Competitive Comparison of Nova Leap Health's Debt-to-EBITDA

For the Medical Care Facilities subindustry, Nova Leap Health's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nova Leap Health's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nova Leap Health's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Nova Leap Health's Debt-to-EBITDA falls into.

Nova Leap Health Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Nova Leap Health's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(3.653	+	1.736)	/	0.571
	=	9.44

Nova Leap Health's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(1.456	+	1.438)	/	3.996
	=	0.72

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2023) EBITDA data.

Nova Leap Health (TSXV:NLH) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Nova Leap Health Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Nova Leap Health's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Nova Leap Health (TSXV:NLH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nova Leap Health Corp (TSXV:NLH) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

NVLPF:USA

Address

7071 Bayers Road, Suite 3006, Halifax, NS, CAN, B3L 2C2

Website

https://www.novaleaphealth.com

Nova Leap Health Corp operates in the healthcare industry. The company is a provider of personal home care and support services. The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offering includes meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S operations. The company derives a majority of its revenue from the United States.

Executives

Christopher Donald Dobbin

Director, Senior Officer

Nova Leap Health (TSXV:NLH) Headlines

No Headlines